Yayın:
Effect of subacute agomelatine treatment on painful diabetic neuropathy: involvement of catecholaminergic mechanisms

Sadeleştirilmiş öğe sayfası
dc.contributor.authorAydın, Taliha H.
dc.contributor.authorDEMİR ÖZKAY, ÜMİDE
dc.contributor.authorCAN, ÖZGÜR DEVRİM
dc.contributor.authorTuran, Nazlı
dc.contributor.orcid0000-0002-2260-3174
dc.contributor.orcid0000-0002-6773-4266
dc.date.accessioned2025-11-13T09:45:45Z
dc.date.issued2016-07-16
dc.identifier.doihttps://doi.org/10.1111/fcp.12224
dc.identifier.endpage567
dc.identifier.issn0767-3981
dc.identifier.issue6
dc.identifier.openalexW2472027592
dc.identifier.startpage549
dc.identifier.urihttps://hdl.handle.net/11421/2114
dc.identifier.urihttps://doi.org/10.1111/fcp.12224
dc.identifier.volume30
dc.language.isoen
dc.relation.ispartofFundamental and Clinical Pharmacology
dc.rightsrestrictedAccess
dc.subjectAgomelatine
dc.subjectAllodynia
dc.subjectNeuropathic pain
dc.subjectMedicine
dc.subjectNociception
dc.subjectDiabetic neuropathy
dc.subjectPhentolamine
dc.subjectHyperalgesia
dc.subjectCatecholaminergic
dc.subjectPharmacology
dc.subjectEndocrinology
dc.subjectInternal medicine
dc.subjectDiabetes mellitus
dc.subjectAnesthesia
dc.subjectCatecholamine
dc.subjectPropranolol
dc.subjectAntidepressant
dc.subjectReceptor
dc.subject.sdg3
dc.titleEffect of subacute agomelatine treatment on painful diabetic neuropathy: involvement of catecholaminergic mechanisms
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5102236821
local.authorid.openalexA5017325490
local.authorid.openalexA5020313406
local.authorid.openalexA5109383324

Dosyalar

Koleksiyonlar

Publications